Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 19: - The gentleman with sudden onset of akathisia on clozapine (Clozaril)
Published online by Cambridge University Press: 03 April 2024
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
What is the main metabolic pathway in the metabolism of clozapine (Clozaril)?
Keywords
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 327 - 344Publisher: Cambridge University PressPrint publication year: 2024
References
Barnes, TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672–6CrossRefGoogle ScholarPubMed
Bayraktar, I˙, Yalçın, N, Demirkan, K. The potential interaction between COVID-19 vaccines and clozapine: a novel approach for clinical trials. Int J Clin Pract 2021; 75(8):e14441CrossRefGoogle ScholarPubMed
Cranshaw, T, Harikumar, T. COVID-19 infection may cause clozapine intoxication: case report and discussion. Schizophr Bull 2020; 46:751CrossRefGoogle Scholar
Edinoff, AN, Fort, JM, Woo, JJ, et al. Selective serotonin reuptake inhibitors and clozapine: clinically relevant interactions and considerations. Neurol Int 2021; 13:445–63CrossRefGoogle ScholarPubMed
Gerlach, J, Lublin, H, Peacock, L. Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine and D1 and D2 dopamine antagonists. Neuropsychopharmacology 1996; 14 Suppl.:35S–39SCrossRefGoogle ScholarPubMed
Jeong, SH, Kim, YS. Challenges in prescribing clozapine in the era of COVID-19: a review focused on immunological implications. Clin Psychopharmacol Neurosci 2021; 19:411–22CrossRefGoogle ScholarPubMed
Loonen, AJM, Stahl, SM. The mechanism of drug-induced akathisia. CNS Spectrums 2011; 16:7–10CrossRefGoogle Scholar
Marder, SR, Essock, SM, Miller, AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161:1334–49CrossRefGoogle ScholarPubMed
Masuda, T, Misawa, F, Takase, M, et al. Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: a systematic review and meta-analysis of cohort studies. JAMA Psychiatry 2019; 76:1052–62CrossRefGoogle ScholarPubMed
Meyer, JM, Stahl, SM. Binding Profile, Metabolism, Kinetics, Drug Interactions and Use of Plasma Levels. Cambridge: Cambridge University Press, 2019, 90–113Google Scholar
Poyurovsky, M. Acute antipsychotic-induced akathisia revisited. Br J Psychiatry 2010; 196:89–91CrossRefGoogle ScholarPubMed
Poyurovsky, M, Weizman, A. Treatment of antipsychotic-induced akathisia: role of serotonin 5-HT2a receptor antagonists. Drugs 2020; 80:871–82CrossRefGoogle Scholar
Pringsheim, T, Gardner, D, Addington, D, et al. The assessment and treatment of antipsychotic-induced akathisia. Can J Psychiatry 2018; 63:719–29Google ScholarPubMed
Roiter, B, Pigato, G, Antonini, A. Prevalence of extrapyramidal symptoms in in-patients with severe mental illnesses: focus on Parkinsonism. Front Neurol 2020; 11:593143CrossRefGoogle ScholarPubMed
Stahl, SM. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics,” 5. Cambridge: Cambridge University Press, 2021.Google Scholar
Tio, N, Schulte, PFJ, Martens, HJM. Clozapine intoxication in COVID-19. Am J Psychiatry 2021; 178:123–7CrossRefGoogle ScholarPubMed
Vermeulen, JM, van Rooijen, G, van de Kerkhof, MPJ, et al. Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1–12.5 years. Schizophr Bull 2019; 45:315–29CrossRefGoogle ScholarPubMed